- Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease
-
Jang H, Kim KY, Kim DS
- KMID: 2418857
- Yonsei Med J.
- 2018 Jan;59(1):113-118.
- doi: 10.3349/ymj.2018.59.1.113
PURPOSE: Intravenous immunoglobulin (IVIG) is the standard treatment for Kawasaki disease (KD). However, there is still no standard treatment for IVIG-resistant KD. This study aimed to evaluate the efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
